111 Capital Buys 5,462 Shares of Encompass Health Corporation $EHC

Key Points

• 111 Capital increased its stake in Encompass Health Corporation by 172.7% during Q2, owning a total of 8,624 shares now valued at approximately $1,058,000.
• Encompass Health recently declared a quarterly dividend of $0.19, up from the previous $0.17, with a payout ratio of 14.87%.
• Several major brokerages raised their target prices on Encompass Health, with Bank of America increasing its target from $145.00 to $160.00 and maintaining a "buy" rating.

111 Capital increased its stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 172.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,624 shares of the company's stock after acquiring an additional 5,462 shares during the period. 111 Capital's holdings in Encompass Health were worth $1,058,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in EHC. Pinnacle Wealth Planning Services Inc. lifted its holdings in shares of Encompass Health by 4.0% in the first quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company's stock valued at $263,000 after purchasing an additional 99 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its position in Encompass Health by 19.0% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock valued at $73,000 after buying an additional 115 shares during the last quarter. UMB Bank n.a. lifted its stake in Encompass Health by 10.9% in the 2nd quarter. UMB Bank n.a. now owns 1,187 shares of the company's stock valued at $146,000 after acquiring an additional 117 shares in the last quarter. Arlington Trust Co LLC boosted its position in Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock worth $68,000 after acquiring an additional 125 shares during the last quarter. Finally, Exchange Traded Concepts LLC grew its stake in shares of Encompass Health by 1.9% during the 2nd quarter. Exchange Traded Concepts LLC now owns 8,095 shares of the company's stock worth $993,000 after acquiring an additional 152 shares in the last quarter. Institutional investors own 97.25% of the company's stock.

Insiders Place Their Bets

In related news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the sale, the executive vice president owned 18,846 shares in the company, valued at approximately $2,329,177.14. This represents a 5.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.00% of the company's stock.

Encompass Health Stock Down 0.3%

EHC opened at $123.13 on Friday. Encompass Health Corporation has a 1-year low of $87.85 and a 1-year high of $127.86. The stock's fifty day simple moving average is $121.25 and its 200 day simple moving average is $115.66. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. The stock has a market cap of $12.40 billion, a PE ratio of 24.10, a price-to-earnings-growth ratio of 2.16 and a beta of 0.93.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The business had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. During the same quarter in the prior year, the business earned $1.11 EPS. The firm's revenue for the quarter was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. As a group, research analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a $0.19 dividend. This is a boost from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date is Wednesday, October 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. Encompass Health's dividend payout ratio (DPR) is currently 14.87%.

Wall Street Analyst Weigh In

Several brokerages recently commented on EHC. KeyCorp increased their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock an "overweight" rating in a report on Tuesday, September 16th. Bank of America increased their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the stock a "buy" rating in a research note on Wednesday, September 10th. UBS Group lifted their target price on Encompass Health from $140.00 to $150.00 and gave the company a "buy" rating in a research report on Thursday. Weiss Ratings reissued a "buy (b+)" rating on shares of Encompass Health in a research report on Saturday, September 27th. Finally, Truist Financial boosted their price target on Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a research report on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating and eight have issued a Buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $139.86.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.